Tax Considerations for Scaling Globally - Hosted by RSM
Tax Considerations for Scaling Globally
An exclusive seminar for life sciences, biotech and medtech companies
As Australian innovation companies grow beyond the start-up phase, international expansion, capital raising and commercialisation can introduce complex tax, transfer pricing and R&D incentive considerations. This practical workshop brings together specialists from RSM's Business Advisory, International Tax and R&D Tax teams to explore the critical tax issues businesses should address when scaling globally.
Attendees will gain insights into structuring for growth and investment, employee share schemes, exit planning, transfer pricing obligations, intellectual property ownership, and cross-border tax risks.
The session will also cover key aspects of the Australian R&D Tax Incentive, including eligibility requirements, overseas R&D activities, aggregated turnover considerations and the impact of expanding internationally on access to incentives.
Designed specifically for founders, CEOs, CFOs, finance leaders and investors in the life sciences, biotechnology and medtech sectors, this seminar will provide practical strategies to help businesses navigate growth, attract investment and maximise the value of their innovation activities in Australia and abroad.
Key topics include:
Structuring for growth, investment and future exit opportunities
Employee Share Schemes (ESS) and ESOPs
Transfer pricing and international expansion considerations
Intellectual property ownership and DEMPE analysis
Cross-border licensing and withholding tax issues
Maximising the Australian R&D Tax Incentive
Overseas R&D activities and foreign expansion
Recent tax developments impacting innovative businesses.
The Bridge and BridgeTech Programs invite all participants and alumni to join for this exclusive seminar.
Join us for an afternoon of practical insights, expert perspectives and networking with industry peers navigating similar growth challenges.